167 related articles for article (PubMed ID: 36814211)
1. Evaluation of the impact of COVID-19 in people coinfected with HIV and/or tuberculosis in low-income countries: study protocol for mixed methods research in Burkina Faso.
Ouattara CA; Poda AG; Méda ZC; Sawadogo Y; Kabore O; Birba E; Sourabié A; Zoungrana J; Traore IT; Sangaré I; Ymba A; Godreuil S; Ouedraogo AS
BMC Infect Dis; 2023 Feb; 23(1):108. PubMed ID: 36814211
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 epidemiological, sociological and anthropological investigation: study protocol for a multidisciplinary mixed methods research in Burkina Faso.
Traoré IT; Ouedraogo S; Kania D; Kaboré FN; Konaté B; Médah R; Badolo H; de Rekeneire N; Kamga AM; Poda A; Diendere AE; Ouédraogo B; Ouédraogo E; Billa O; Tinto H; Dabakuyo-Yonli TS
BMC Infect Dis; 2021 Sep; 21(1):896. PubMed ID: 34479501
[TBL] [Abstract][Full Text] [Related]
3. Patients infected by tuberculosis and human immunodeficiency virus facing their disease, their reactions to disease diagnosis and its implication about their families and communities, in Burkina Faso: a mixed focus group and cross sectional study.
Méda ZC; Somé T; Sombié I; Maré D; Morisky DE; Chen YM
BMC Res Notes; 2016 Jul; 9():373. PubMed ID: 27473578
[TBL] [Abstract][Full Text] [Related]
4. Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13).
Kaboré NF; Ouédraogo S; Mamguem AK; Traoré IT; Kania D; Badolo H; Sanou G; Koné A; Yara M; Kagoné T; Ouédraogo E; Konaté B; Médah R; de Rekeneire N; Poda A; Diendéré AE; Ouédraogo B; Billa O; Paradis G; Dabakuyo-Yonli TS; Tinto H
BMC Infect Dis; 2023 Jun; 23(1):394. PubMed ID: 37308819
[TBL] [Abstract][Full Text] [Related]
5. The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population-based, age-stratified sero-epidemiological investigation.
Ouedraogo S; Traoré IT; Kania D; Kaboré NF; Mamguem Kamga A; Badolo H; Yara M; Sanou G; Koné A; Kagoné ST; Ouédraogo E; Konaté B; Médah R; de Rekeneire N; Poda A; Diendere AE; Ouédraogo B; Billa O; Paradis G; Tinto H; Dabakuyo-Yonli TS
Influenza Other Respir Viruses; 2023 Nov; 17(11):e13216. PubMed ID: 38019697
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country.
Kaboré OD; Poda A; Ouattara CA; Michodigni FN; Belem AA; Sawadogo Y; Zoungrana J; Galal L; Meda CZ; Godreuil S; Ouédraogo AS
PLoS One; 2023; 18(6):e0286665. PubMed ID: 37315090
[TBL] [Abstract][Full Text] [Related]
7. Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection: a systematic review and meta-analysis (from November 2019 to March 2021).
Wang Q; Guo S; Wei X; Dong Q; Xu N; Li H; Zhao J; Sun Q
BMJ Open; 2022 Jun; 12(6):e059396. PubMed ID: 35725250
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of SARS-CoV-2 and
Shah T; Shah Z; Yasmeen N; Baloch Z; Xia X
Front Immunol; 2022; 13():909011. PubMed ID: 35784278
[TBL] [Abstract][Full Text] [Related]
9. TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection.
Luke E; Swafford K; Shirazi G; Venketaraman V
Front Biosci (Schol Ed); 2022 Mar; 14(1):6. PubMed ID: 35320917
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.
Crisan-Dabija R; Grigorescu C; Pavel CA; Artene B; Popa IV; Cernomaz A; Burlacu A
Can Respir J; 2020; 2020():1401053. PubMed ID: 32934758
[TBL] [Abstract][Full Text] [Related]
11. Enigma of the high prevalence of anti-SARS-CoV-2 antibodies in HIV-positive people with no symptoms of COVID-19 in Burkina Faso.
Sagna T; Ouedraogo P; Traore L; Obiri-Yeboah D; Yonli A; Tapsoba A; Tovo F; Sorgho A; Zongo L; Nikiema O; Ilboudo D; Belemgnegre M; Nadembega CW; Ouermi D; Djigma FW; Zohoncon TM; Poaty H; Colizzi V; Simpore J
J Public Health Afr; 2022 May; 13(1):1778. PubMed ID: 35720802
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of tuberculosis infection among HIV/AIDS patients in Burkina Faso.
Méda ZC; Sombié I; Sanon OW; Maré D; Morisky DE; Chen YM
AIDS Res Hum Retroviruses; 2013 Jul; 29(7):1045-55. PubMed ID: 23517547
[TBL] [Abstract][Full Text] [Related]
13. Medication-adherence predictors among patients with tuberculosis or human immunodeficiency virus infection in Burkina Faso.
Méda ZC; Lin YT; Sombié I; Maré D; Morisky DE; Chen YM
J Microbiol Immunol Infect; 2014 Jun; 47(3):222-32. PubMed ID: 23769812
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of SARS-CoV-2 and co-infection with malaria during the first wave of the pandemic (the Burkina Faso case).
López-Farfán D; Yerbanga RS; Parres-Mercader M; Torres-Puente M; Gómez-Navarro I; Sanou DMS; Yao AF; Bosco Ouédraogo J; Comas I; Irigoyen N; Gómez-Díaz E
Front Public Health; 2022; 10():1048404. PubMed ID: 36579069
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological, Virological and Serological Features of Coronavirus Disease 2019 (COVID-19) Cases in People Living With Human Immunodeficiency Virus in Wuhan: A Population-based Cohort Study.
Huang J; Xie N; Hu X; Yan H; Ding J; Liu P; Ma H; Ruan L; Li G; He N; Wei S; Wang X
Clin Infect Dis; 2021 Oct; 73(7):e2086-e2094. PubMed ID: 32803216
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, Epidemiological, and Clinical Profile of Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis in the Coronavirus Disease 2019 Context in Health Facilities in the East Region, Cameroon.
François Anicet OA; Kouanfack C; Dama U; Nkfusai CN; Abanda JN; Tchoffo D; Mbu PN; Yoniene PY
Int J MCH AIDS; 2024; 13():e006. PubMed ID: 38742165
[TBL] [Abstract][Full Text] [Related]
17. Immune Dysregulation in SARS-CoV-2 patients coinfected with Mycobacterium tuberculosis (Mtb) or HIV in China.
Li L; Zhang J; Sun R; Liu H; Cheng G; Fan F; Wang C; Li A; Liang H; Yu Z; Wang G; Ren Z
BMC Public Health; 2024 Feb; 24(1):556. PubMed ID: 38388348
[TBL] [Abstract][Full Text] [Related]
18. The COVID-19, tuberculosis and HIV/AIDS: Ménage à Trois.
Udoakang AJ; Djomkam Zune AL; Tapela K; Nganyewo NN; Olisaka FN; Anyigba CA; Tawiah-Eshun S; Owusu IA; Paemka L; Awandare GA; Quashie PK
Front Immunol; 2023; 14():1104828. PubMed ID: 36776887
[TBL] [Abstract][Full Text] [Related]
19. Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses.
Sarkar S; Khanna P; Singh AK
J Med Virol; 2021 Apr; 93(4):2385-2395. PubMed ID: 33331656
[TBL] [Abstract][Full Text] [Related]
20. A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and
González-Domenech CM; Pérez-Hernández I; Gómez-Ayerbe C; Viciana Ramos I; Palacios-Muñoz R; Santos J
Viruses; 2021 May; 13(5):. PubMed ID: 34067925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
